Shan Yang

12.8k total citations
59 papers, 1.3k citations indexed

About

Shan Yang is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Shan Yang has authored 59 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 15 papers in Oncology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Shan Yang's work include Breast Cancer Treatment Studies (6 papers), Genomics and Phylogenetic Studies (6 papers) and Ophthalmology and Visual Impairment Studies (4 papers). Shan Yang is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), Genomics and Phylogenetic Studies (6 papers) and Ophthalmology and Visual Impairment Studies (4 papers). Shan Yang collaborates with scholars based in China, United States and United Kingdom. Shan Yang's co-authors include Francesca Chiaromonte, Ross C. Hardison, Webb Miller, Scott Schwartz, Laura Elnitski, Elbert Branscomb, Stuart Huntley, Lisa Stubbs, Mary Bao Tran-Gyamfi and Joomyeong Kim and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Shan Yang

51 papers receiving 1.3k citations

Peers

Shan Yang

GENET

ONCOL

Yinghao Cao China

Lifang Hu China

Qian Du China

Shelley Force Aldred United States

Wei‐Wen Cai United States

Muhammad Rafiq Pakistan

Minchul Kim South Korea

Shu Tao China

Xiaodan Lv China

Liya Pi United States

Yinghao Cao China

Shan Yang

428 ×0.5

177 ×0.5

GENET

392 ×1.4

309 ×2.3

ONCOL

129 ×1.0

Citations per year, relative to Shan Yang Shan Yang (= 1×) peers Yinghao Cao

Countries citing papers authored by Shan Yang

Since Specialization

Citations

This map shows the geographic impact of Shan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shan Yang more than expected).

Fields of papers citing papers by Shan Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shan Yang. The network helps show where Shan Yang may publish in the future.

Co-authorship network of co-authors of Shan Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Shan Yang. A scholar is included among the top collaborators of Shan Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shan Yang. Shan Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Feng, Xin, et al.. (2025). Risk of Ophthalmotoxicity Associated with Antibody-Drug Conjugates: A Systematic Review and Meta-analysis. Clinical Drug Investigation. 45(6). 295–308.

Yang, Shan, Jiangfeng Wang, Xuejian Xie, et al.. (2025). Identification and formation mechanism of threading screw dislocations in 4H-SiC crystal. Journal of Alloys and Compounds. 1040. 183454–183454.

Yang, Shan, et al.. (2025). DNMT3A facilitates breast cancer progression via regulating ADAMTS8 mediated EGFR-MEK-ERK activation. PLoS ONE. 20(5). e0321889–e0321889.

Chen, Mengting, Zhichao He, Jianhong Zhu, et al.. (2024). Hemorrhage profile associated with immune checkpoint inhibitors: a systematic review and a real-world study based on the FAERS database. Expert Opinion on Drug Safety. 23(4). 497–511. 3 indexed citations

Huang, Jian, et al.. (2024). Edge Computing for Microgrid via MATLAB Embedded Coder and Low-Cost Smart Meters. 234–239. 1 indexed citations

Yang, Shan, Wei Gao, Haoqi Wang, et al.. (2023). Role of PAX2 in breast cancer verified by bioinformatics analysis and in vitro validation. Annals of Translational Medicine. 11(2). 58–58. 5 indexed citations

He, Zhichao, Jianhong Zhu, Dan Liang, et al.. (2023). Thromboembolism profiles associated with cyclin-dependent kinase 4/6 inhibitors: a real-world pharmacovigilance study and a systematic review. Expert Opinion on Drug Safety. 22(7). 599–609. 6 indexed citations

He, Zhichao, Wei Jiang, Jianhong Zhu, et al.. (2023). Interstitial lung disease in patients treated with poly (ADP-ribose) polymerase inhibitors (PARPi): analysis of results from clinical trials and the FDA Adverse Events Reporting System database. International Journal of Gynecological Cancer. 33(8). 1237–1246. 1 indexed citations

Li, Sainan, Huimin Wang, Xuejiao Ma, et al.. (2023). An Analysis of Clinical and Pathologic Features, RecurIndex Genomic Profiles, and Survival Outcomes in HER2-Low Breast Cancer. The Oncologist. 28(12). e1160–e1169. 4 indexed citations

10.

He, Wei, et al.. (2023). Evaluating Histological Subtypes Classification of Primary Lung Cancers on Unenhanced Computed Tomography Based on Random Forest Model. Journal of Healthcare Engineering. 2023(1). 8964676–8964676. 3 indexed citations

11.

Yang, Shan, et al.. (2023). Short-Term Impact of Different Corneal Incision Positions on Postoperative Astigmatism and Visual Quality After SMILE Surgery. Ophthalmology and Therapy. 12(5). 2453–2464.

12.

Yang, Shan, et al.. (2023). Hydrolyzed Conchiolin Protein (HCP) Extracted from Pearls Antagonizes both ET-1 and α-MSH for Skin Whitening. International Journal of Molecular Sciences. 24(8). 7471–7471. 5 indexed citations

13.

He, Zhichao, Wenxia Zhao, Shan Yang, et al.. (2022). SGLT-2 inhibitors and euglycemic diabetic ketoacidosis/diabetic ketoacidosis in FAERS: a pharmacovigilance assessment. Acta Diabetologica. 60(3). 401–411. 18 indexed citations

14.

Deng, Yudi, et al.. (2021). Reinforcing vascular normalization therapy with a bi-directional nano-system to achieve therapeutic-friendly tumor microenvironment. Journal of Controlled Release. 340. 87–101. 42 indexed citations

15.

Zhang, Xi, Jiajie Shi, Sainan Li, et al.. (2021). Antibiotics modulate neoadjuvant therapy efficiency in patients with breast cancer: a pilot analysis. Scientific Reports. 11(1). 14024–14024. 25 indexed citations

16.

Jiang, Zhijie, Hui Xiong, Shan Yang, et al.. (2020). Jet‐Lagged Nanoparticles Enhanced Immunotherapy Efficiency through Synergistic Reconstruction of Tumor Microenvironment and Normalized Tumor Vasculature. Advanced Healthcare Materials. 9(12). e2000075–e2000075. 36 indexed citations

17.

Li, Sainan, Shan Yang, Jiajie Shi, et al.. (2020). Recognition of the organ-specific mutations in metastatic breast cancer by circulating tumor cells isolated in vivo.. Neoplasma. 68(1). 31–39. 6 indexed citations

18.

Wang, Na, Rong‐Miao Zhou, Chunmei Wang, et al.. (2011). −251 T/A polymorphism of the interleukin-8 gene and cancer risk: a HuGE review and meta-analysis based on 42 case–control studies. Molecular Biology Reports. 39(3). 2831–2841. 51 indexed citations

19.

Huntley, Stuart, Aaron T. Hamilton, Mary Bao Tran-Gyamfi, et al.. (2006). A comprehensive catalog of human KRAB-associated zinc finger genes: Insights into the evolutionary history of a large family of transcriptional repressors. Genome Research. 16(5). 669–677. 261 indexed citations

20.

Hardison, Ross C., Francesca Chiaromonte, Diana L. Kolbe, et al.. (2003). Global Predictions and Tests of Erythroid Regulatory Regions. Cold Spring Harbor Symposia on Quantitative Biology. 68(0). 335–344. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact